99% Savings - Buy Just @1 Rs X
Olmesafe H 12.5/20 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Other than this, Olmesafe H 12.5/20 Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Olmesafe H 12.5/20 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The most common side effects of Olmesafe H 12.5/20 Tablet are Upper respiratory tract infection. Besides the aforementioned side effects, there are other adverse effects of Olmesafe H 12.5/20 Tablet as well, which are listed below. Such side effects of Olmesafe H 12.5/20 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Olmesafe H 12.5/20 Tablet's effect during pregnancy is Severe and Mild while nursing. It is important to know if Olmesafe H 12.5/20 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olmesafe H 12.5/20 Tablet related warnings section.
Olmesafe H 12.5/20 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Olmesafe H 12.5/20 Tablet in conditions like Asthma, Allergy, Kidney Disease. The section on Olmesafe H 12.5/20 Tablet contraindications lists all such conditions.
Drug reaction of Olmesafe H 12.5/20 Tablet with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Olmesafe H 12.5/20 Tablet is not safe while driving, and is not addiction.
Olmesafe H 12.5/20 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmesafe H 12.5/20 Tablet safe for pregnant women?
Olmesafe H has many dangerous side effects in pregnant women. If you are pregnant, do not consume Olmesafe H without medical advice.
Is the use of Olmesafe H 12.5/20 Tablet safe during breastfeeding?
Olmesafe H has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olmesafe H 12.5/20 Tablet on the Kidneys?
Olmesafe H may have mild side effects on the kidneys.
What is the effect of Olmesafe H 12.5/20 Tablet on the Liver?
Olmesafe H is rarely harmful for the liver.
What is the effect of Olmesafe H 12.5/20 Tablet on the Heart?
Olmesafe H has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Olmesafe H 12.5/20 Tablet unless your doctor advises you to do so -
Is this Olmesafe H 12.5/20 Tablet habit forming or addictive?
Forming a habit of Olmesafe H 12.5/20 Tablet has not been reported.
Interaction between Food and Olmesafe H 12.5/20 Tablet
Olmesafe H 12.5/20 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Olmesafe H 12.5/20 Tablet
Consuming Olmesafe H 12.5/20 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173